Which condition should NOT be treated with Zofran without base/ modified base consultation?

Which condition should NOT be treated with Zofran without base/ modified base consultation?

• A. < 4 y/o
• B. Pregnant
• C. Over 65
• D. Renal disease

Answer: (A)

Zofran (ondansetron) in EMS is handled with extra caution for very young children because dosing data and safety monitoring in that age group are more limited. When a patient is under 4 years old, bases or modified base physicians typically must approve use to ensure the dose is correct and to assess any cardiac risk, electrolyte issues, or drug interactions in a setting without full hospital resources. That need for clinician oversight makes this age group the one that should not be treated with Zofran without base consultation. In contrast, for other groups listed, Zofran is commonly used under standing orders or with standard precautions in EMS, though clinicians still consider pregnancy status, age, and kidney function for dosing and risk, these do not automatically require base consultation in many protocols.

Zofran (ondansetron) in EMS is handled with extra caution for very young children because dosing data and safety monitoring in that age group are more limited. When a patient is under 4 years old, bases or modified base physicians typically must approve use to ensure the dose is correct and to assess any cardiac risk, electrolyte issues, or drug interactions in a setting without full hospital resources. That need for clinician oversight makes this age group the one that should not be treated with Zofran without base consultation.

In contrast, for other groups listed, Zofran is commonly used under standing orders or with standard precautions in EMS, though clinicians still consider pregnancy status, age, and kidney function for dosing and risk, these do not automatically require base consultation in many protocols.